ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer
CompletedOBSERVATIONAL
Enrollment
45
Participants
Timeline
Start Date
May 10, 2018
Primary Completion Date
July 15, 2021
Study Completion Date
July 15, 2021
Conditions
Breast Cancer
Interventions
DEVICE
Ultrasound
Breast ultrasound
Trial Locations (1)
27599
University of North Carolina, Chapel Hill
All Listed Sponsors
lead
UNC Lineberger Comprehensive Cancer Center
OTHER
NCT03785782 - ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer | Biotech Hunter | Biotech Hunter